|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 301 to 314 out of 314 for Nras

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.021s

Categories

Category: Publication
Type Details Score
Publication
First Author: Uka R
Year: 2020
Journal: Oncogene
Title: Temporal activation of WNT/β-catenin signaling is sufficient to inhibit SOX10 expression and block melanoma growth.
Volume: 39
Issue: 20
Pages: 4132-4154
Publication
First Author: Schaefer SM
Year: 2017
Journal: Oncogene
Title: Sox2 is dispensable for primary melanoma and metastasis formation.
Volume: 36
Issue: 31
Pages: 4516-4524
Publication  
First Author: Zingg D
Year: 2015
Journal: Nat Commun
Title: The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors.
Volume: 6
Pages: 6051
Publication
First Author: Vandamme N
Year: 2020
Journal: Cancer Res
Title: The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like Phenotype.
Volume: 80
Issue: 14
Pages: 2983-2995
Publication      
First Author: Lazar I
Year: 2022
Journal: J Invest Dermatol
Title: Adipocyte Extracellular Vesicles Decrease p16INK4A in Melanoma: An Additional Link between Obesity and Cancer.
Publication
First Author: Sohier P
Year: 2018
Journal: Pigment Cell Melanoma Res
Title: A histopathological classification system of Tyr::NRAS(Q61K) murine melanocytic lesions: A reproducible simplified classification.
Volume: 31
Issue: 3
Pages: 423-431
Publication
First Author: van der Weyden L
Year: 2016
Journal: J Pathol
Title: Cross-species models of human melanoma.
Volume: 238
Issue: 2
Pages: 152-65
Publication
First Author: Olvedy M
Year: 2017
Journal: J Clin Invest
Title: Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma.
Volume: 127
Issue: 6
Pages: 2310-2325
Publication
First Author: Zingg D
Year: 2018
Journal: Cancer Cell
Title: EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma Formation.
Volume: 34
Issue: 1
Pages: 69-84.e14
Publication
First Author: Varum S
Year: 2019
Journal: Cell Stem Cell
Title: Yin Yang 1 Orchestrates a Metabolic Program Required for Both Neural Crest Development and Melanoma Formation.
Volume: 24
Issue: 4
Pages: 637-653.e9
Publication
First Author: Karras P
Year: 2022
Journal: Nature
Title: A cellular hierarchy in melanoma uncouples growth and metastasis.
Volume: 610
Issue: 7930
Pages: 190-198
Publication  
First Author: Kirschner LS
Year: 2016
Journal: Mol Cell Endocrinol
Title: Mouse models of thyroid cancer: A 2015 update.
Volume: 421
Pages: 18-27
Publication
First Author: Huttlin EL
Year: 2010
Journal: Cell
Title: A tissue-specific atlas of mouse protein phosphorylation and expression.
Volume: 143
Issue: 7
Pages: 1174-89
Publication
First Author: Church DM
Year: 2009
Journal: PLoS Biol
Title: Lineage-specific biology revealed by a finished genome assembly of the mouse.
Volume: 7
Issue: 5
Pages: e1000112